202 related articles for article (PubMed ID: 12183556)
1. Ganglioside mimicry of Campylobacter jejuni lipopolysaccharides determines antiganglioside specificity in rabbits.
Ang CW; Noordzij PG; de Klerk MA; Endtz HP; van Doorn PA; Laman JD
Infect Immun; 2002 Sep; 70(9):5081-5. PubMed ID: 12183556
[TBL] [Abstract][Full Text] [Related]
2. Guillain-Barré syndrome- and Miller Fisher syndrome-associated Campylobacter jejuni lipopolysaccharides induce anti-GM1 and anti-GQ1b Antibodies in rabbits.
Ang CW; De Klerk MA; Endtz HP; Jacobs BC; Laman JD; van der Meché FG; van Doorn PA
Infect Immun; 2001 Apr; 69(4):2462-9. PubMed ID: 11254608
[TBL] [Abstract][Full Text] [Related]
3. Structure of Campylobacter jejuni lipopolysaccharides determines antiganglioside specificity and clinical features of Guillain-Barré and Miller Fisher patients.
Ang CW; Laman JD; Willison HJ; Wagner ER; Endtz HP; De Klerk MA; Tio-Gillen AP; Van den Braak N; Jacobs BC; Van Doorn PA
Infect Immun; 2002 Mar; 70(3):1202-8. PubMed ID: 11854201
[TBL] [Abstract][Full Text] [Related]
4. [Campylobacter jejuni enteritis and Guillain-Barré syndrome].
Yuki N
Rinsho Byori; 1999 Aug; 47(8):713-8. PubMed ID: 10511801
[TBL] [Abstract][Full Text] [Related]
5. Tolerance to self gangliosides is the major factor restricting the antibody response to lipopolysaccharide core oligosaccharides in Campylobacter jejuni strains associated with Guillain-Barré syndrome.
Bowes T; Wagner ER; Boffey J; Nicholl D; Cochrane L; Benboubetra M; Conner J; Furukawa K; Furukawa K; Willison HJ
Infect Immun; 2002 Sep; 70(9):5008-18. PubMed ID: 12183547
[TBL] [Abstract][Full Text] [Related]
6. Lipopolysaccharides in the development of the Guillain-Barré syndrome and Miller Fisher syndrome forms of acute inflammatory peripheral neuropathies.
Prendergast MM; Moran AP
J Endotoxin Res; 2000; 6(5):341-59. PubMed ID: 11521055
[TBL] [Abstract][Full Text] [Related]
7. Molecular mimicry between gangliosides and lipopolysaccharides of Campylobacter jejuni isolated from patients with Guillain-Barré syndrome and Miller Fisher syndrome.
Yuki N
J Infect Dis; 1997 Dec; 176 Suppl 2():S150-3. PubMed ID: 9396700
[TBL] [Abstract][Full Text] [Related]
8. Pathogenesis of Guillain-Barré and Miller Fisher syndromes subsequent to Campylobacter jejuni enteritis.
Yuki N
Jpn J Infect Dis; 1999 Jun; 52(3):99-105. PubMed ID: 10507987
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal antibodies raised against Guillain-Barré syndrome-associated Campylobacter jejuni lipopolysaccharides react with neuronal gangliosides and paralyze muscle-nerve preparations.
Goodyear CS; O'Hanlon GM; Plomp JJ; Wagner ER; Morrison I; Veitch J; Cochrane L; Bullens RW; Molenaar PC; Conner J; Willison HJ
J Clin Invest; 1999 Sep; 104(6):697-708. PubMed ID: 10491405
[TBL] [Abstract][Full Text] [Related]
10. Guillain-Barré syndrome-related Campylobacter jejuni in Bangladesh: ganglioside mimicry and cross-reactive antibodies.
Islam Z; Gilbert M; Mohammad QD; Klaij K; Li J; van Rijs W; Tio-Gillen AP; Talukder KA; Willison HJ; van Belkum A; Endtz HP; Jacobs BC
PLoS One; 2012; 7(8):e43976. PubMed ID: 22952833
[TBL] [Abstract][Full Text] [Related]
11. Current cases in which epitope mimicry is considered a component cause of autoimmune disease: Guillain-Barré syndrome.
Yuki N
Cell Mol Life Sci; 2000 Apr; 57(4):527-33. PubMed ID: 11130452
[TBL] [Abstract][Full Text] [Related]
12. Campylobacter jejuni lipopolysaccharides from Guillain-Barré syndrome patients induce IgG anti-GM1 antibodies in rabbits.
Ang CW; Endtz HP; Jacobs BC; Laman JD; de Klerk MA; van der Meché FG; van Doorn PA
J Neuroimmunol; 2000 May; 104(2):133-8. PubMed ID: 10713352
[TBL] [Abstract][Full Text] [Related]
13. Induction of antibodies reactive with GM2 ganglioside after immunization with lipopolysaccharides from Camplyobacter jejuni.
Ritter G; Fortunato SR; Cohen L; Noguchi Y; Bernard EM; Stockert E; Old LJ
Int J Cancer; 1996 Apr; 66(2):184-90. PubMed ID: 8603809
[TBL] [Abstract][Full Text] [Related]
14. Is Campylobacter lipopolysaccharide bearing a GD3 epitope essential for the pathogenesis of Guillain-Barré syndrome?
Yuki N; Koga M; Hirata K
Acta Neurol Scand; 2000 Aug; 102(2):132-4. PubMed ID: 10949532
[TBL] [Abstract][Full Text] [Related]
15. Ganglioside-induced antiganglioside antibodies from a neuropathy patient cross-react with lipopolysaccharides of Campylobacter jejuni associated with Guillain-Barré syndrome.
Neisser A; Schwerer B; Bernheimer H; Moran AP
J Neuroimmunol; 2000 Jan; 102(1):85-8. PubMed ID: 10626671
[TBL] [Abstract][Full Text] [Related]
16. Recognition characteristics of monoclonal antibodies that are cross-reactive with gangliosides and lipooligosaccharide from Campylobacter jejuni strains associated with Guillain-Barré and Fisher syndromes.
Houliston RS; Yuki N; Hirama T; Khieu NH; Brisson JR; Gilbert M; Jarrell HC
Biochemistry; 2007 Jan; 46(1):36-44. PubMed ID: 17198373
[TBL] [Abstract][Full Text] [Related]
17. Humoral immune response against Campylobacter jejuni lipopolysaccharides in Guillain-Barré and Miller Fisher syndrome.
Jacobs BC; Endtz HP; van der Meché FG; Hazenberg MP; de Klerk MA; van Doorn PA
J Neuroimmunol; 1997 Oct; 79(1):62-8. PubMed ID: 9357448
[TBL] [Abstract][Full Text] [Related]
18. Guillain-Barré syndrome and Fisher's syndrome following Campylobacter jejuni infection.
Yuki N; Miyatake T
Ann N Y Acad Sci; 1998 Jun; 845():330-40. PubMed ID: 9668366
[TBL] [Abstract][Full Text] [Related]
19. Carbohydrate mimicry of Campylobacter jejuni lipooligosaccharide is critical for the induction of anti-GM1 antibody and neuropathy.
Shu XM; Cai FC; Zhang XP
Muscle Nerve; 2006 Feb; 33(2):225-31. PubMed ID: 16270308
[TBL] [Abstract][Full Text] [Related]
20. [Measurement of antiganglioside autoantibodies by immunodot-blot assay: clinical importance in peripheral neuropathies].
Caudie C; Vial C; Petiot P; Bancel J; Later R; Gonnaud PM
Ann Biol Clin (Paris); 1999; 57(5):579-88. PubMed ID: 10518060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]